FDA Resolves Semaglutide Shortage
This is a news story, published by CNBC, that relates primarily to GLP-1s news.
GLP-1s news
For more GLP-1s news, you can click here:
more GLP-1s newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsCNBC news
For more news from CNBC, you can click here:
more news from CNBCAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
semaglutide injection products. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Novo Nordisk news, FDA news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
blockbuster weight loss drugs WegovyCNBC
•Health
Health
Shares of Hims & Hers tumble 23% after FDA says semaglutide is no longer in shortage

81% Informative
Semaglutide is the active ingredient in Novo Nordisk's weight loss drugs Wegovy and Ozempic .
Demand for the GLP-1s has exploded in recent years .
Digital health companies like Hims & Hers have been prescribing compounded medications.
The FDA said Friday that it will start taking action against compounders for violations in the next 60 to 90 days .
VR Score
77
Informative language
76
Neutral language
22
Article tone
formal
Language
English
Language complexity
57
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
5
Source diversity
4
Affiliate links
no affiliate links